| Overview |
| bsm-62923r-cy7-100ul |
| NSDHL Recombinant Monoclonal Antibody, Cy7 Conjugated |
| WB, IF(ICC) |
| Human |
| Specifications |
| Cy7 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human NSDHL |
| Monoclonal |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 50814 |
| Q15738 |
| Cell membrane |
| H105E3; NSDHL; SDR31E1; XAP104. |
| Catalyzes the NAD(P)+-dependent oxidative decarboxylation of the C4 methyl groups of 4-alpha-carboxysterols in post-squalene cholesterol biosynthesis (By similarity).Also plays a role in the regulation of the endocytic trafficking of EGFR (By similarity). |
| Application Dilution |
| WB |
1:300-5000 |
| IF(ICC) |
1:50-200 |
Powered by Bioz